An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission
Clinical trial NCT05413018 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05413018
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-19
- Primary completion
- 2025-10-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.